James F. Oliviero III - 18 Dec 2024 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
CEO, President and Director, Director
Signature
/s/ James F. Oliviero, III
Issuer symbol
CKPT
Transactions as of
18 Dec 2024
Net transactions value
-$3,074,764
Form type
4
Filing time
20 Dec 2024, 21:30:54 UTC
Previous filing
17 Dec 2024
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Sale $2,330,386 -602,167 -15% $3.87 3,414,813 18 Dec 2024 Direct F1, F2, F3
transaction CKPT COMMON STOCK Sale $744,377 -220,230 -6.4% $3.38 3,194,583 19 Dec 2024 Direct F1, F3, F4
transaction CKPT COMMON STOCK Gift $0 -900,000 -28% $0.000000 2,294,583 20 Dec 2024 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the vesting of 2,111,033 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F2 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.66 to $4.27. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes shares of restricted common stock, which vest over various time periods.
F4 Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.33 to $3.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F5 On December 20, 2024, 900,000 shares of common stock were transferred into an irrevocable trust for the benefit of Mr. Oliviero's minor children. Mr. Oliviero is not a trustee of the trust and has no investment control over the securities held by the trust.